Azerbaijan vs Egypt: HIV-positive TB patients on ART (antiretroviral therapy)
Azerbaijan
100.0%
in 2024
Egypt
100.0%
in 2024
Azerbaijan rank
1st
Egypt rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Azerbaijan
- Egypt
How they compare
Azerbaijan currently reports 100.0% against 100.0% in Egypt, a difference of 0.0%.
Across all 14 years both countries report, Egypt has been ahead every year.
Azerbaijan ranks 1st and Egypt ranks 1st of 144 countries.
Egypt has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Azerbaijan | Egypt | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 73.8% | 100.0% | 26.2% | Egypt |
| 2020s | 98.2% | 100.0% | 1.8% | Egypt |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Azerbaijan or Egypt?
- Azerbaijan, at 100.0% against 100.0% in Egypt as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Azerbaijan and Egypt?
- 0.0%, with Azerbaijan ahead.
- How many years of comparable data are there for Azerbaijan and Egypt?
- 14 years are reported by both, from 2011 to 2024.
- How do Azerbaijan and Egypt rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Azerbaijan ranks 1st and Egypt ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.